重庆医学
重慶醫學
중경의학
CHONGQING MEDICAL JOURNAL
2015年
16期
2205-2207
,共3页
周超%陈宗良%周全华%吴国辉%周颖
週超%陳宗良%週全華%吳國輝%週穎
주초%진종량%주전화%오국휘%주영
获得性免疫缺陷性综合征%危性性行为%抗病毒药%治疗结果
穫得性免疫缺陷性綜閤徵%危性性行為%抗病毒藥%治療結果
획득성면역결함성종합정%위성성행위%항병독약%치료결과
acquired immunodeficiency syndrome%onsafe sex%antiviral agents%treatment outcone
目的:了解重庆市男男性行为(MSM)人群艾滋病患者抗病毒治疗基本情况,评估不同基线CD4+T淋巴细胞数水平的抗病毒治疗效果。方法在国家艾滋病综合防治信息系统中收集资料,以患者开始治疗时基线CD4+T淋巴细胞数水平分类,采用回顾性队列研究方法观察和评估治疗效果,数据运用SPSS18.0软件进行统计分析。结果1758例治疗患者平均年龄(33.5±11.1)岁,CD4+T<50个/μL、50~199个/μL、200~350个/μL、>350个/μL者分别占7.7%、27.6%、54.9%、9.7%,治疗12个月后CD4+T值分别维持在150~250个/μL、250~350个/μL、350~450个/μL、450~550个/μL,治疗6个月后病毒载量抑制比例分别为70.2%、81.7%、84.2%、83.3%,治疗36个月生存率分别为0.81、0.93、0.98、1.00。结论MSM人群艾滋病抗病毒治疗取得显著效果,早期治疗更有利于该人群免疫功能恢复,降低艾滋病病死率,控制疫情。
目的:瞭解重慶市男男性行為(MSM)人群艾滋病患者抗病毒治療基本情況,評估不同基線CD4+T淋巴細胞數水平的抗病毒治療效果。方法在國傢艾滋病綜閤防治信息繫統中收集資料,以患者開始治療時基線CD4+T淋巴細胞數水平分類,採用迴顧性隊列研究方法觀察和評估治療效果,數據運用SPSS18.0軟件進行統計分析。結果1758例治療患者平均年齡(33.5±11.1)歲,CD4+T<50箇/μL、50~199箇/μL、200~350箇/μL、>350箇/μL者分彆佔7.7%、27.6%、54.9%、9.7%,治療12箇月後CD4+T值分彆維持在150~250箇/μL、250~350箇/μL、350~450箇/μL、450~550箇/μL,治療6箇月後病毒載量抑製比例分彆為70.2%、81.7%、84.2%、83.3%,治療36箇月生存率分彆為0.81、0.93、0.98、1.00。結論MSM人群艾滋病抗病毒治療取得顯著效果,早期治療更有利于該人群免疫功能恢複,降低艾滋病病死率,控製疫情。
목적:료해중경시남남성행위(MSM)인군애자병환자항병독치료기본정황,평고불동기선CD4+T림파세포수수평적항병독치료효과。방법재국가애자병종합방치신식계통중수집자료,이환자개시치료시기선CD4+T림파세포수수평분류,채용회고성대렬연구방법관찰화평고치료효과,수거운용SPSS18.0연건진행통계분석。결과1758례치료환자평균년령(33.5±11.1)세,CD4+T<50개/μL、50~199개/μL、200~350개/μL、>350개/μL자분별점7.7%、27.6%、54.9%、9.7%,치료12개월후CD4+T치분별유지재150~250개/μL、250~350개/μL、350~450개/μL、450~550개/μL,치료6개월후병독재량억제비례분별위70.2%、81.7%、84.2%、83.3%,치료36개월생존솔분별위0.81、0.93、0.98、1.00。결론MSM인군애자병항병독치료취득현저효과,조기치료경유리우해인군면역공능회복,강저애자병병사솔,공제역정。
Objective To know basic characteristics of MSM infected with HIV treated by highly active antiretroviral thera‐py(HAART) ,and evaluate therapeutic effect based on the level of CD4+ T cell counts .Methods Basic database of patients were collected from the national AIDS comprehensive data information system ,patients were observed by the retrospective cohort study , and effect indicators were analyzed based on the level of CD4+ T cell counts .The data was analyzed by SPSS18 .0 software .Results A total of 1 758 cases were recruited in this study and the average age was (33 .5 ± 11 .1)years .The component ratio of the CD4+T cell counts <50/μL ,50 to 199/μL ,200 to 350/μL ,> 350/μL were 7 .7% ,27 .6% ,54 .9% ,9 .7% ,respectively .The CD4+ T counts increased and kept among 150 to 250/μL ,250 to 350/μL ,350 to 450/μL ,450 to 550/μL ,respectively after 12 months ,treat‐ment .The rates of viral inhibition were 70 .2% ,81 .7% ,84 .2% ,83 .3% ,respectively after 6 months′treatment .And the cumulative survival rates were 0 .81 ,0 .93 ,0 .98 ,1 .0 after 36 ,months treatment ,respectively .Conclusion HAART on MSM achieves remarka‐ble results .And the early treatment was more beneficial to improve immune function ,reduce AIDS mortality and control the HIV/AIDS epidemic of MSM .